In the kidney, miRNA-192-5p contributes to protection against hypertension through the target gene ATP1B1 (β1 subunit of Na+/K+-ATPase), and miR-192-5p levels are significantly decreased in humans with hypertension or hypertensive nephrosclerosis [66]. The gene discussed is ATP1B1; the disease is Hypertension.